The global bacterial and viral specimen collection market size is anticipated to reach USD 33.37 billion by 2030 and expand at a CAGR of 14.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growing burden of infectious diseases such as COVID-19, influenza, and tuberculosis has significantly increased the demand for bacterial and viral specimen collection. As healthcare systems strive to contain outbreaks and improve patient outcomes, governments and private sectors are ramping up healthcare investments. This surge in healthcare spending supports expanded diagnostic testing, better infrastructure, and the development of efficient specimen collection tools, ultimately driving market growth.
Technological advancements in diagnostics, including PCR, molecular assays, and rapid test platforms, have revolutionized the way infections are detected. These innovations require reliable and high-quality specimen collection methods to ensure accuracy. In addition, rising awareness among healthcare providers and patients about the importance of early and precise diagnosis increases testing volumes, thereby fueling demand for advanced specimen collection tools and boosting the overall market size.
The shift toward decentralized healthcare, driven by the convenience and accessibility of home testing and point-of-care diagnostics, is reshaping the specimen collection landscape. These trends reduce reliance on traditional lab settings and increase sample collection frequency. In addition, expanding research and clinical trials for vaccines, therapeutics, and infectious disease surveillance are boosting demand for standardized specimen collection kits, contributing significantly to the market’s growth and broadening its application across various sectors.
Request a free sample copy or view report summary: Bacterial And Viral Specimen Collection Market Report
By product, the viral specimen collection segment led the market with the largest revenue share of 57.3% in 2024, attributed to the rising prevalence of viral infections, including influenza, hepatitis, and emerging viral outbreaks.
By application, the diagnostics segment dominated the market with the largest share in 2024, driven bythe growing demand for accurate and early disease detection.
The research segment is projected to witness significant growth from 2025 to 2030 due to technological advancements in diagnostic tools, such as next-generation sequencing and multiplex PCR, which enhance the accuracy and efficiency of specimen analysis.
The home testing segment is anticipated to be the fastest-growing segment during the forecast period,fueled by increasing consumer demand for convenient, private, and accessible diagnostic solutions.
North America accounted for the largest revenue share of 45% in 2024, propelled by the high prevalence of infectious diseases, substantial healthcare investments, advanced infrastructure, and robust research and development initiatives.
Grand View Research has segmented the global bacterial and viral specimen collection market based on product, application, end use, and region:
Bacterial And Viral Specimen Collection Market Product Outlook (Revenue, USD Billion, 2018 - 2030)
Bacterial Specimen Collection
Swabs
Bacterial Transport Media
Blood Collection Kits
Other Consumables
Viral Specimen Collection
Swabs
Viral Transport Media
Blood Collection Kits
Other Consumables
Bacterial And Viral Specimen Collection Market Application Outlook (Revenue, USD Billion, 2018 - 2030)
Diagnostics
Research
Bacterial And Viral Specimen Collection Market End Use Outlook (Revenue, USD Billion, 2018 - 2030)
Hospitals & Clinics
Home Testing
Research Laboratories
Bacterial And Viral Specimen Collection Market Region Outlook (Revenue, USD Billion, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Bacterial And Viral Specimen Collection Market
Puritan Medical Products
Copan Diagnostics Inc.
BD (Becton, Dickinson and Company)
Thermo Fisher Scientific Inc.
QuidelOrtho Corporation
Longhorn Vaccines and Diagnostics, LLC
Pretium Packaging
Trinity Biotech
Medical Wire & Equipment
HiMedia Laboratories, LLC
Hardy Diagnostics
Wuxi NEST Biotechnology Co., Ltd. (Nest Scientific)
VIRCELL SL
DiaSorin S.p.A.
Titan Biotech
"The quality of research they have done for us has been excellent..."